Table 2.
Correlation between the lncRNA gene expression and the clinical and laboratory data of the studied patients.
| Parameters | GAS5 gene |
LY86-AS1 gene |
HCG27_201 gene |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diabetic group |
Pre-diabetic group |
Diabetic group |
Pre-diabetic group |
Diabetic group |
Pre-diabetic group |
|||||||
| r | P | R | p | r | p | r | p | r | P | r | p | |
| Age/years | 0.087 | 0.460 | 0.269 | 0.030* | −0.035 | 0.766 | −0.003 | 0.980 | −0.205 | 0.078 | −0.221 | 0.077 |
| Disease duration | 0.066 | 0.574 | – | – | −0.135 | 0.248 | – | – | −0.172 | 0.141 | --- | ---- |
| BMI (kg/m2) | 0.212 | 0.068 | −0.181 | 0.148 | 0.145 | 0.216 | 0.136 | 0.279 | −0.125 | 0.284 | −0.288 | 0.020* |
| FBG (mg/dl) | −0.313 | 0.006** | −0.192 | 0.125 | −0.043 | 0.716 | 0.214 | 0.087 | −0.343 | 0.003** | 0.140 | 0.265 |
| 2-HPPG (mg/dl) | 0.128 | 0.274 | 0.062 | 0.624 | −0.034 | 0.773 | 0.00 | 0.999 | −0.281 | 0.015* | 0.116 | 0.358 |
| HbA1c (%) | −0.252 | 0.029* | 0.027 | 0.829 | −0.353 | 0.002** | −0.252 | 0.043* | −0.054 | 0.645 | −0.094 | 0.456 |
| HDLc (mg/dl) | −0.122 | 0.295 | 0.146 | 0.245 | −0.072 | 0.540 | 0.020 | 0.876 | 0.075 | 0.520 | −0.132 | 0.293 |
| T. cholesterol (mg/dl) | −0.021 | 0.855 | 0.090 | 0.474 | 0.120 | 0.305 | −0.281 | 0.023* | −0.001 | 0.996 | 0.111 | 0.381 |
| TGs (mg/dl) | 0.192 | 0.100 | −0.066 | 0.601 | −0.069 | 0.555 | 0.154 | 0.221 | 0.027 | 0.817 | −0.211 | 0.091 |
| LDL (mg/dl) | −0.031 | 0.794 | 0.125 | 0.322 | 0.152 | 0.192 | 0.219 | 0.080 | −0.007 | 0.956 | 0.190 | 0.129 |
rs: Spearman coefficient **Highly significant.